Prokidney (PROK) Gains from Investment Securities (2021 - 2026)
Prokidney (PROK) reported Gains from Investment Securities of $3000.0 for Q1 2026, down 99.99% year-over-year from $30.4 million in Q1 2025, and down 99.4% quarter-over-quarter from $500000.0 in Q4 2025.
Prokidney (PROK) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Gains from Investment Securities data on file, last reported at $3000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $3000.0, down 99.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $480000.0 (down 98.42% YoY), and the FY2025 annual result was $27.5 million, up 28.0% from the prior year.
- Gains from Investment Securities fell to $3000.0 in Q1 2026 per PROK's latest filing, from $500000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $30.5 million in Q2 2025 and troughed at -$96000.0 in Q4 2024.
- A 5-year average of $12.6 million and a median of $15.7 million in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 196386.65% in 2023, then plunged 231.51% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $129370.0 in 2022, then sank by 43.57% to $73000.0 in 2023, then sank by 231.51% to -$96000.0 in 2024, then jumped by 620.83% to $500000.0 in 2025, then plunged by 99.4% to $3000.0 in 2026.
- Business Quant data shows PROK's Gains from Investment Securities at $3000.0 in Q1 2026, $500000.0 in Q4 2025, and $29.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | 29.09 Mn |
| Sep 30, 2025 | 29.09 Mn |
| Jun 30, 2025 | 30.50 Mn |
| Jun 30, 2025 | 30.50 Mn |
| Mar 31, 2025 | 30.38 Mn |
| Mar 31, 2025 | 30.38 Mn |
| Dec 31, 2024 | -96,000.00 |
| Dec 31, 2024 | -96,000.00 |
| Sep 30, 2024 | 22.08 Mn |
| Sep 30, 2024 | 22.08 Mn |
| Jun 30, 2024 | 21.92 Mn |
| Jun 30, 2024 | 21.92 Mn |
| Mar 31, 2024 | 21.85 Mn |
| Mar 31, 2024 | 21.85 Mn |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2023 | 73,000.00 |